You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
MiniMed does not review or control the content on the other website, and is not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site will not be licensed for sale in United States.
MiniMed’s Smallest App-Controlled Insulin Pump is Now Available in the U.S.
Six-month randomized trial found 8.1 percentage points more Time in Range and 0.6 percentage points lower HbA1c among higher responders. NORTHRIDGE, Calif., Oct. 5, 2026 /PRNewswire/ -- MiniMed...
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Sheila Denton has been named General Counsel & Corporate Secretary. "Sheila brings deep board experience,...
MiniMed (Nasdaq: MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in connection with Medtronic plc's ("Medtronic";...